Cargando…

Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease Successfully Treated with Anakinra

Macrophage activation syndrome (MAS) is a potentially fatal complication of Adult-Onset Still's disease (Still's disease). Whereas an increasing body of evidence supports interleukin-1 (IL-1) blockade as a promising treatment for Still's disease, whether it is therapeutic for MAS asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Aswini, Kato, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080478/ https://www.ncbi.nlm.nih.gov/pubmed/27818826 http://dx.doi.org/10.1155/2016/3717392

Ejemplares similares

Anakinra Hepatotoxicity in a Patient With Adult-Onset Still's Disease
por: Ahmed, Osman, et al.
Publicado: (2015)

Pulmonary Arterial Hypertension in Adult-Onset Still's Disease: Rapid Response to Anakinra
por: Campos, Marc, et al.
Publicado: (2012)

Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still’s disease: when dosage matters in overcoming secondary therapy resistance
por: Ajeganova, Sofia, et al.
Publicado: (2020)

Adult-onset Still’s disease: Switch to atypical skin manifestations under anakinra therapy
por: Klapproth, Henning, et al.
Publicado: (2023)

Adult‐onset Still's disease complicated by macrophage activation syndrome
por: Awoyemi, Toluwalase, et al.
Publicado: (2023)

Anakinra in children and adults with Still’s disease
por: Vastert, Sebastiaan J, et al.
Publicado: (2019)

A Recurrent Case of Adult-onset Still's Disease with Concurrent Acalculous Cholecystitis and Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis Successfully Treated with Combination Immunosuppressive Therapy
por: Arai, Yuri, et al.
Publicado: (2021)

Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8 mg/kg/d) of anakinra
por: Parisi, Federico, et al.
Publicado: (2017)

Multisystem Inflammatory Syndrome in an Adult (MIS-A) Successfully Treated with Anakinra and Glucocorticoids
por: Cattaneo, Paolo, et al.
Publicado: (2021)

Successful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease: A Case-Based Review
por: Watanabe, Eri, et al.
Publicado: (2016)

Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still’s Disease
por: Levy, Ofer, et al.
Publicado: (2022)

Erythroderma and persistent erythema in adult-onset Still disease associated with macrophage activation syndrome
por: Madray, Victoria M., et al.
Publicado: (2021)

Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review
por: Ortiz-Sanjuán, Francisco, et al.
Publicado: (2015)

Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response
por: Vitale, Antonio, et al.
Publicado: (2019)

Adult-onset Still's Disease during Pregnancy Treated with Tocilizumab
por: Imaizumi, Chihiro, et al.
Publicado: (2022)

Possible macrophage activation syndrome following initiation of adalimumab in a patient with adult-onset still's disease
por: Souabni, Leila, et al.
Publicado: (2014)

A Diagnostic Dilemma: Adult-Onset Still’s Disease With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome?
por: Parkash, Om, et al.
Publicado: (2023)

Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety
por: Hong, Dongsheng, et al.
Publicado: (2014)

Anakinra in Still’s disease: a profile of its use
por: Lyseng-Williamson, Katherine A.
Publicado: (2018)

Activation mechanisms of monocytes/macrophages in adult-onset Still disease
por: Tsuboi, Hiroto, et al.
Publicado: (2022)

Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes
por: Vitale, Antonio, et al.
Publicado: (2020)

Intravenous administration of anakinra in children with macrophage activation syndrome
por: Phadke, Omkar, et al.
Publicado: (2021)

Recurrent Kikuchi-Fujimoto Disease Masquerading as Lymphoma Successfully Treated by Anakinra
por: Faheem, Beenish, et al.
Publicado: (2020)

Successful Treatment with Intravenous Cyclophosphamide for Refractory Adult-Onset Still's Disease
por: Tsuji, Yoshika, et al.
Publicado: (2015)

Adult-onset Still’s disease complicated by macrophage activation syndrome during pregnancy: a case-based review
por: Wise, Leanna, et al.
Publicado: (2023)

Perimyocarditis as first sign of systemic onset juvenile idiopathic arthritis treated successfully with anakinra: a case-based review
por: Ciancia, Silvia, et al.
Publicado: (2020)

A child with resistant Kawasaki disease successfully treated with anakinra: a case report
por: Sánchez-Manubens, J., et al.
Publicado: (2017)

IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome
por: Baggio, Chiara, et al.
Publicado: (2023)

Correction to: Anakinra in Still’s disease: a profile of its use
por: Lyseng‑Williamson, Katherine A.
Publicado: (2018)

A Case of Macrophage Activation Syndrome During the Treatment of Adult-onset Still’s Disease With Tocilizumab
por: Lee, Ju Ho, et al.
Publicado: (2022)

Adult-Onset Still’s Disease Presenting as Macrophage-Activation Syndrome With Critical Illness in the Third Trimester of Pregnancy: A Case Report
por: Peters, Andrew T., et al.
Publicado: (2021)

Refractory Sweet Syndrome Treated with Anakinra
por: Shahid, Zainab, et al.
Publicado: (2019)

Elderly-onset Still's Disease Complicated by Macrophage Activation Syndrome: A Case Report and Review of the Literature
por: Suda, Takuya, et al.
Publicado: (2019)

Severe Adult-onset Still Disease with Constrictive Pericarditis and Pleuritis That Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A
por: Kawaguchi, Hoshimi, et al.
Publicado: (2017)

Chronic Autoimmune Meningoencephalitis and Periodic Fever Syndrome Treated with Anakinra
por: Novroski, Alyssa-Rae, et al.
Publicado: (2017)

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
por: Sota, Jurgen, et al.
Publicado: (2019)

Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome
por: Bossi, Grazia, et al.
Publicado: (2022)

Myositis, Vasculitis, Hepatic Dysfunction in Adult-Onset Still's Disease
por: Yanai, Hidekatsu, et al.
Publicado: (2009)

Erratum in: Budget Impact Analysis of anakinra in the treatment of patients with Still’s Disease
por: Ravasio, Roberto, et al.
Publicado: (2020)

A Challenging Case of Adult-Onset Still's Disease Complicated by Macrophage Activation Syndrome With Multiorgan Failure
por: Mohamed, Abdelaziz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ghvugv33e529n0u41svrki6re9